Thorn Scott 4
4 · Algorhythm Holdings, Inc. · Filed Mar 31, 2026
Research Summary
AI-generated summary of this filing
Algorhythm (RIME) Director Thorn Scott Receives Equity Awards
What Happened
Thorn Scott, a director of Algorhythm Holdings, Inc. (RIME), was granted two equity awards on November 20, 2025: a restricted stock award (RSA) for 19,532 shares and a non‑qualified stock option (NQSO) covering 39,063 shares. Both grants are reported at $0.00 (typical for awards/grants) and are grants rather than purchases or sales.
Key Details
- Transaction date: November 20, 2025. Form filed March 31, 2026 (filing appears late).
- Reported price: $0.00 for both the RSA and the option (transaction code A = Award/Grant).
- RSA: 19,532 shares (contingent right to receive shares).
- NQSO: option to purchase 39,063 shares (derivative).
- Vesting: both awards vest in equal quarterly installments over one year from the grant date (see footnotes F1–F3).
- Shares owned after the transaction: not specified in the provided filing.
- Timeliness: the Form 4 was filed well after the 2‑business‑day window (transactionTimeliness = L), reducing near‑term transparency.
Context
The RSA is a restricted stock grant that will convert into actual shares as it vests; the NQSO is a right to buy shares in the future as it vests — neither represents an immediate sale or exercise. Such director equity grants are common as compensation and do not by themselves indicate insider buying or selling intent.
Insider Transaction Report
- Award
Common Stock
[F1]2025-11-20+19,532→ 19,532 total - Award
Stock Option (right to buy)
[F2][F3]2025-11-20+39,063→ 39,063 totalExercise: $1.28Exp: 2035-11-20→ Common Stock (39,063 underlying)
Footnotes (3)
- [F1]The reported transaction involved the Reporting Person's receipt of a restricted stock award for 19,532 shares of the Issuer's common stock (the "RSA"). The RSA was granted pursuant to the Algorhythm Holdings, Inc. 2022 Equity Incentive Plan. The RSA represents a contingent right to receive 19,532 shares of the Issuer's common stock. The RSA vests in equal quarterly installments over a period of one year from the date of grant.
- [F2]The reported transaction involved the Reporting Person's receipt of a non-qualified stock option to purchase 39,063 shares of the Issuer's common stock. The option was granted pursuant to the Algorhythm Holdings, Inc. 2022 Equity Incentive Plan.
- [F3]The shares subject to the non-qualified stock option vest and become exercisable in equal quarterly installments over a period of one (1) year from the date of grant.